Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

Speakers

  • Catherine E. Lai, MD, MPH | Penn Medicine
  • Elizabeth Olson Hexner, MD | Penn Medicine
  • Pashna N. Mushni, MD | Penn Medicine
  • Daria V. Babushok, MD, PhD | Penn Medicine
  • Ximena Jordan Bruno, MD | Penn Medicine
  • Elise A. Chong, MD | Penn Medicine

Topics

  • Treatment of Patients With Myelofibrosis
  • Current and Future Treatments for Chronic GVHD
  • Treatment Pathways for Patients With PNH
  • Emerging Treatment Standards for MDS
  • Sequencing BTK Inhibitors in CLL
  • Therapeutic Approaches to AML

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Justin M. Watts, MD
Mazyar Shadman, MD, MPH
Craig Eckfeldt, MD, PhD, assistant professor, medicine, faculty, Microbiology, Immunology, and Cancer Biology PhD Graduate Program, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Mark Juckett, MD, professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Hannah Choe, MD, an expert on GVHD
Hannah Choe, MD, an expert on GVHD
Grzegorz S. Nowakowski, MD
Combination of Zanubrutinib + Venetoclax for Treatment-naive CLL/SLL With del(17p) and/or TP53: Preliminary Results From SEQUOIA Arm D
Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients With Relapsed or Refractory CLL/SLL: Results From the Phase 1 BGB-16673-101 Study